Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yu-Heng Zhu

Matched on OpenAlex author ID A5031010995. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 3 papers · 2025: 3 papers · 2026: 1 paper

Papers 10

  1. A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neuron.2026.03.039↗
  2. Vitamin D Binding Protein, a Ligand of Integrin beta 1, Motivates Both Tumor Cells and Schwann Cells to Promote Perineural Invasion in Pancreatic Ductal Adenoc… Co-author DOI 10.1002/advs.202511726↗
  3. An in-vivo pilot study of probe-based confocal laser endomicroscopy for detecting of pancreatic ductal adenocarcinoma intraoperatively. Co-author DOI 10.1097/js9.0000000000003754↗
  4. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. Co-author DOI 10.7150/ijbs.104598↗
  5. A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. First author DOI 10.1016/j.celrep.2024.114633↗
  6. OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. Co-author DOI 10.1016/j.gene.2024.148735↗
  7. The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway. Co-author DOI 10.1186/s12935-024-03440-z↗
  8. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. Co-author DOI 10.1007/s10495-023-01843-3↗
  9. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. Co-author DOI 10.1007/s13402-022-00741-1↗
  10. Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/ph15111336↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong‐Fei Yao · 10 shared papers, 2022–2026 · strength 1.89
  2. Qin-Yuan Jia · 7 shared papers, 2022–2025 · strength 1.25
  3. Zong‐Hao Duan · 6 shared papers, 2022–2025 · strength 1.10
  4. Yongwei Sun · 6 shared papers, 2022–2025 · strength 1.10
  5. Yan‐Miao Huo · 5 shared papers, 2023–2025 · strength 0.91
  6. Jia-Hao Zheng · 5 shared papers, 2023–2024 · strength 0.89
  7. Shu‐Heng Jiang · 4 shared papers, 2023–2026 · strength 0.76
  8. Li-Peng Hu · 3 shared papers, 2024–2026 · strength 0.58
  9. Jian‐Yu Yang · 3 shared papers, 2022–2024 · strength 0.47
  10. Jian Yang · 3 shared papers, 2022–2024 · strength 0.47
  11. Luju Jiang · 2 shared papers, 2025–2026 · strength 0.41
  12. Shuqi Cai · 2 shared papers, 2025–2026 · strength 0.41
  13. Xiaomei Yang · 2 shared papers, 2025–2026 · strength 0.41
  14. Rong Hua · 2 shared papers, 2025–2026 · strength 0.41
  15. Yifan Yin · 2 shared papers, 2024–2025 · strength 0.40
  16. Qing Li · 2 shared papers, 2024–2025 · strength 0.38
  17. Junfeng Zhang · 2 shared papers, 2024–2026 · strength 0.38
  18. Yifan Yin · 2 shared papers, 2024 · strength 0.38
  19. Minwei Yang · 2 shared papers, 2023–2025 · strength 0.38
  20. Dejun Liu · 2 shared papers, 2024–2026 · strength 0.38
  21. Dejun Liu · 2 shared papers, 2022–2023 · strength 0.31
  22. Pei‐Xuan Ji · 2 shared papers, 2022–2024 · strength 0.31
  23. Chunjing Li · 1 shared paper, 2025 · strength 0.24
  24. Zhiwei Cai · 1 shared paper, 2025 · strength 0.24
  25. Chongyi Jiang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.